2019
DOI: 10.1111/ajd.13059
|View full text |Cite
|
Sign up to set email alerts
|

A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor

Abstract: PEODDN is a congenital hamartoma, adult-onset cases have been described. 1 Histopathological examination shows an epidermal invagination with a parakeratotic column placed over a hyperplastic eccrine duct with a dilated acrosyringium and loss of the granular layer. 1 The exact pathogenesis of PEODDN is unclear. Positive immunohistochemical staining for carcinoembryonic antigen along the eccrine duct lumina and acrosyringium through the parakeratotic column of the cornoid lamellae leads to a suggestion that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…These reactions have included palmoplantar pustulosis 3 and widespread molluscum. 4 The precise mechanisms underlying inflammatory skin reactions in response to JAK inhibition are not completely understood. It is hypothesised that the interference with JAK-mediated signalling may disrupt the delicate balance between proinflammatory and anti-inflammatory cytokines, subsequently driving an overactive immune response within the skin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These reactions have included palmoplantar pustulosis 3 and widespread molluscum. 4 The precise mechanisms underlying inflammatory skin reactions in response to JAK inhibition are not completely understood. It is hypothesised that the interference with JAK-mediated signalling may disrupt the delicate balance between proinflammatory and anti-inflammatory cytokines, subsequently driving an overactive immune response within the skin.…”
Section: Discussionmentioning
confidence: 99%
“…Dermatological reactions to baricitinib have been infrequently reported in the medical literature. These reactions have included palmoplantar pustulosis 3 and widespread molluscum 4 . The precise mechanisms underlying inflammatory skin reactions in response to JAK inhibition are not completely understood.…”
Section: Discussionmentioning
confidence: 99%